Sadra Medical raises $30M for aortic valve replacement

Sadra Medical, which is developing a procedure to replace the aortic valve (for the less medically-savvy, that’s part of your heart), has raised $30 million in a third round of funding. The Campbell, Calif., company dubs its procedure “percutaneous aortic valve replacement,” and it involves… Continue Reading

Neovista sees $18M to treat eye disorders

Neovista, a Fremont, Calif.-based biotech company specializing in eye diseases, says it raised $18 million in a fourth round of funding to commercialize its new device. The money came from Accuitive Medical Ventures, Carlyle Group, Essex Woodlands Health Ventures, MPM Capital, SV Life Sciences and… Continue Reading

Nevro raises $22 million for pain therapy

Nevro Corp. has raised $22 million in a first round of funding. The Palo Alto, Calif. company is conducting clinical trials for its neuromodulation therapy for chronic pain. New investor Accuitive Medical Ventures joined return investors Aberdare Ventures, Bay City Capital, Mayo Clinic, MPM Capital… Continue Reading

MyoScience raises $10.4M for aesthetic medicine

MyoScience, a stealth-mode medical company based in Redwood City, Calif., has taken $10.4 million in a second funding for continuing clinical trials.

The company has not yet disclosed exactly what use its aesthetic devices will have, although CEO Lisa Elkins hinted that aging eyes and skin… Continue Reading

Life-science briefing: Tuesday, March 25, 2008

Life-science briefing: Tuesday, March 25, 2008

TODAY’S HEADLINES:

Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes… Continue Reading

Life sciences briefing: Wednesday, Dec. 5, 2007

Life sciences briefing: Wednesday, Dec. 5, 2007

Featured companies: AxoGen, Cognition Therapeutics, Ester Neurosciences, Gene Security Network, HealthTalk, MPM Capital, Revolution Health, SparkPeople

UPDATING: Expanded items on AxoGen, Ester and Cognition. Posted full items on MPM (link) and Gene Security Network (link).

AxoGen raises $12M for nerve regeneration — AxoGen, an Alachua, Fla., biotech focused on… Continue Reading

Funding roundup: Announcements that got away

Funding roundup: Announcements that got away

Although I try to stay on top of events in the life sciences, announcements do sometimes manage to slip through the cracks. Some days, in fact, I end up triaging. Because the roots of this site — not to mention many of its readers —… Continue Reading

WaveTec Vision Systems takes in $13M for intraocular lens replacement

WaveTec Vision Systems of Aliso Viejo, Calif., raised $13 million in a second round of funding, PEHub reports. The company is developing a system to improve patient outcomes in intraocular lens replacement surgeries. The deal was led by Accuitive Medical Ventures and De Novo Ventures,… Continue Reading

NeoVista, a co. targeting age-related macular degeneration, raises $41M

NeoVista, a Fremont ophthalmic device company focusing on the treatment of wet age-related macular degeneration, said it has raised a third $41 million round of venture financing.

The company is in the early stages of testing its technology, and it won’t hit the market until around… Continue Reading